NCT01324635View on ClinicalTrials.gov

Panobinostat and Stereotactic Radiation Therapy in Treating Patients With Brain Tumors

PHASE1TerminatedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2016

Conditions
Recurrent GliomaHigh-grade MeningiomaBrain Metastasis
Interventions
DRUG

Panobinostat

Given PO

RADIATION

Stereotactic body radiation therapy

Undergo SBRT

PROCEDURE

Quality-of-life assessment

Ancillary studies

RADIATION

Stereotactic radiosurgery

Undergo stereotactic radiosurgery

Trial Locations (1)

19107

Thomas Jefferson University, Philadelphia

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Sidney Kimmel Cancer Center at Thomas Jefferson University

OTHER